Filipe Pereira
31 – 40 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Compositions for reprogramming into dendritic cells type 2 competent for antigen presentation, methods and uses thereof
2021) WO2021105234(
- Patent › Patent
-
Mark
Compositions for reprogramming cells into plasmacytoid dendritic cells or interferon producing cells, methods and uses thereof
2021) WO2021069672(
- Patent › Patent
-
Mark
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
(
- Contribution to journal › Scientific review
-
Mark
Reprogramming Stars #2 : Reprogramming towards Neural Lineages - An Interview with Dr. Henrik Ahlenius
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Restoring the immunogenicity of cancer cells with dendritic cell reprogramming
(
- Contribution to journal › Published meeting abstract
-
Mark
GATA2 at the mitosis-to-G1 transition is critical for definitive hematopoiesis
2021) 2021 Virtual Annual Scientific Meeting of the ISEH - International Society for Experimental Hematology: ISEH 50th Annual Meeting In Experimental Hematology 100(Suppl). p.35-35(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
Mononuclear phagocyte regulation by the transcription factor Blimp-1 in health and disease
(
- Contribution to journal › Scientific review
-
Mark
A SOX2 reporter system identifies gastric cancer stem-like cells sensitive to monensin
(
- Contribution to journal › Article
-
Mark
Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors
(
- Contribution to journal › Article
- 2019
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
(
- Contribution to journal › Debate/Note/Editorial